|
BR122021024397A2
(enExample)
|
|
|
|
BR122021000189A2
(enExample)
|
|
|
|
BR122022025811B8
(enExample)
|
|
|
|
BR122022008542B1
(pt)
|
|
Uso de um composto e composição farmacêutica o compreendendo
|
|
BR122021023687A2
(enExample)
|
|
|
|
BR122021014832A2
(enExample)
|
|
|
|
BR122022003521A2
(enExample)
|
|
|
|
BR202017010814U2
(enExample)
|
|
|
|
BR202017010373U2
(enExample)
|
|
|
|
BR202017009870U2
(enExample)
|
|
|
|
BR202017006953U2
(enExample)
|
|
|
|
BR202017004898U2
(enExample)
|
|
|
|
BR202017002937U2
(enExample)
|
|
|
|
BR202017002826U2
(enExample)
|
|
|
|
CN303995820S
(enExample)
|
|
|
|
CN304007160S
(enExample)
|
|
|
|
CN303998319S
(enExample)
|
|
|
|
CN303998256S
(enExample)
|
|
|
|
CN303999594S
(enExample)
|
|
|
|
CN303698284S9
(enExample)
|
|
|
|
CN304002638S
(enExample)
|
|
|
|
CN303995432S
(enExample)
|
|
|
|
CN303991579S
(enExample)
|
|
|
|
CN303949240S9
(enExample)
|
|
|
|
CN303948614S9
(enExample)
|
|
|